| Old Articles: <Older 44391-44400 Newer> |
|---|
 |
The Motley Fool
September 29, 2010
Brian Orelli |
Better Buy: Spectrum Pharmaceuticals or Dendreon? A battle of the sales-ramping drugmakers.   |
The Motley Fool
September 29, 2010
Matt Koppenheffer |
Are Stocks Actually Cheap? Is this popular signal saying that stocks are cheap right now? |
The Motley Fool
September 29, 2010
Andrew Bond |
As Trading Slows, So Do Investment Banks Slowdown in trading volumes is slowing bank profits. |
The Motley Fool
September 29, 2010
Andrew Bond |
Walgreen Surprises the Experts Walgreen posts a great quarter as competition falters. |
The Motley Fool
September 29, 2010
Brian Orelli |
Careful What You Wish For, Stem Cell Investors Investors seem to have forgotten about fundamentals. |
The Motley Fool
September 29, 2010
Anders Bylund |
Danaher: Still Hungry! Danaher is on a multi-year buyout rampage to consolidate an entire industry. |
The Motley Fool
September 29, 2010
Matt Koppenheffer |
Unilever Lathers Up Alberto-Culver Unilever agreed to acquire Alberto-Culver. |
The Motley Fool
September 29, 2010 |
Adobe Could Face Lingering Challenges in Education Markets As classroom technology becomes better and more ubiquitous, how will Adobe fare? |
The Motley Fool
September 29, 2010
Seth Jayson |
Does This Mean Tidewater Will Bomb Next Quarter? Is Tidewater sending any warning signs? |
The Motley Fool
September 29, 2010
Wolfgang Gruener |
5 Reasons Why Firefox Does Not Need the iPhone Where is the sweet spot for Mozilla? It's not with the iPhone. |
| <Older 44391-44400 Newer> Return to current articles. |
